Fortrea Holdings (FTRE) Other Working Capital Changes (2022 - 2026)
Fortrea Holdings (FTRE) reported Other Working Capital Changes of $6.6 million for Q1 2026, down 36.54% on a YoY basis from $10.4 million in Q1 2025, and down 89.04% quarter-over-quarter from $60.2 million in Q4 2025.
Fortrea Holdings (FTRE) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Other Working Capital Changes for 5 years, with the latest figure at $6.6 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 36.54% year-over-year to $6.6 million; the trailing twelve-month figure through Mar 2026 stood at $111.0 million (up 78.74% YoY), and the FY2025 full-year result was $114.8 million, up 46.99% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $6.6 million, down from $60.2 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $79.1 million in Q3 2025, with the low at -$45.1 million in Q4 2022.
- Historically, Other Working Capital Changes has averaged $10.9 million across 5 years, with a median of $7.8 million in 2024.
- The largest YoY upside for Other Working Capital Changes was 8888.89% in 2025 against a maximum downside of 547.44% in 2025.
- Fortrea Holdings' Other Working Capital Changes stood at -$45.1 million in 2022, then surged by 120.84% to $9.4 million in 2023, then surged by 376.6% to $44.8 million in 2024, then soared by 34.38% to $60.2 million in 2025, then slumped by 89.04% to $6.6 million in 2026.
- The last three Other Working Capital Changes figures came in at $6.6 million (Q1 2026), $60.2 million (Q4 2025), and $79.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.60 Mn |
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | 60.20 Mn |
| Dec 31, 2025 | 60.20 Mn |
| Sep 30, 2025 | 79.10 Mn |
| Sep 30, 2025 | 79.10 Mn |
| Jun 30, 2025 | -34.90 Mn |
| Jun 30, 2025 | -34.90 Mn |
| Mar 31, 2025 | 10.40 Mn |
| Mar 31, 2025 | 10.40 Mn |
| Dec 31, 2024 | 44.80 Mn |
| Dec 31, 2024 | 44.80 Mn |
| Sep 30, 2024 | -900,000.00 |
| Sep 30, 2024 | -900,000.00 |
| Jun 30, 2024 | 7.80 Mn |
| Jun 30, 2024 | 7.80 Mn |
| Mar 31, 2024 | 26.40 Mn |
| Mar 31, 2024 | 26.40 Mn |
| Dec 31, 2023 | 9.40 Mn |
| Dec 31, 2023 | 9.40 Mn |